开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Yawei Luo
Drug Repurposing opportunities arise from potential observations, discussions, and collaborations, including the development of different meaningful platforms for the identification of drugs and their potential targets and allow the accessing of compounds. Drug Repurposing is an approach that uses the existing approved/failed drug for novel clinical use. This approach has the advantage that the compounds have already undergone different drug discovery phases and have sufficient information related to safety, efficacy, formulation, dose, and potential toxicity. As a result, this strategy is gaining considerable attention in drug research because of its cost-effective and time-saving capabilities. In recent years many pharmaceuticals are utilizing this approach for their drug discovery and development program, in fact in the Covid-19 era, its utility increased by many folds.